Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
https://www.nature.com/articles/pcan201657.pdf
Reference22 articles.
1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027–2035.
2. Roobol MJ, Steyerberg EW, Kranse R, Wolters T, van den Bergh RC, Bangma CH et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010; 57: 79–85.
3. Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol 2012; 61: 577–583.
4. Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J et al. The Prostate Cancer Prevention Trial Risk Calculator 2.0 for the prediction of low- versus high-grade prostate cancer. Urology 2014; 83: 1362–1367.
5. Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S et al. Assessing individual risk for prostate cancer. J Clin Oncol 2007; 25: 3582–3588.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk calculators for the detection of prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-06-03
2. Artificial intelligence-aided detection for prostate cancer with multimodal routine health check-up data: an Asian multi-center study;International Journal of Surgery;2023-11-20
3. External validation of the Rotterdam Prostate Cancer Risk Calculator within a Dutch high-risk clinical cohort;Tijdschrift voor Urologie;2023-04-21
4. External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort;World Journal of Urology;2022-10-16
5. A multicenter retrospective study on evaluation of predicative factors for positive biopsy of prostate cancer in real-world setting;Current Medical Research and Opinion;2021-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3